A new blood test could help identify the earliest biological warning signs of ovarian cancer before invasive tumours develop, potentially giving women at increased risk more time to make crucial decisions about their health.
Ovarian cancer remains particularly challenging to diagnose because early symptoms can be difficult to recognise, and existing imaging techniques often miss very small abnormalities.